The Foundation to prevent antibiotic resistance
To reduce the use of antibiotics in animal production was the reason for the formation of BioGaia 28 years ago. Ever since, antibiotic resistance has been a central issue for the company. In 2015 a decision was taken to broaden the commitment and make antibiotic resistance BioGaia’s main focus within sustainability.
This year, 2018, the Board of Directors of BioGaia decided to start a foundation to contribute to the fight against antibiotic resistance. The tasks of the Foundation include, among other things, funding research and development of products and methods that prevent infection by strengthening the immune system of humans and animals. The Foundation will provide stipends and research grants as well as support education and the spread of information aiming at reaching this objective. Funds for stipends and grants come from BioGaia, which established the Foundation.
The Foundation will
- Support, stimulate and reward research, education and information activities in Sweden which aim to reduce the use of antibiotics through preventive measures that improve the immune system of humans and animals.
- Provide stipends and research grants as well as supporting education. Recipients can be companies and individuals who conduct research or work with education or information in Sweden. Funds for stipends and grants will come from BioGaia which established the Foundation. In 2018 there is SEK 4 million to be allocated.
Supporting the fight against antibiotic resistance
The Foundation was formed to support the fight against antibiotic resistance by funding research and development of products and methods that prevent infection by strengthening the immune system of humans and animals More information through the Foundation's website
In 1928 Scottish scientist Alexander Fleming discovered that a fungus had destroyed some of the bacteria he was studying. He named the substance it released penicillin, but didn’t understand its effect. In 1945 production started and soon several other antibiotics were discovered.
How resistance is developed
Antibiotics are drugs that are used to kill bacteria that cause infections. But every time an antibiotic is used, some of the bacteria will survive. Over time, these “survivors” multiply and form a new strain that is resistant to the antibiotic.
What is antibiotic resistance?
Antibiotic resistance is the ability of pathogenic bacteria to resist the effects of antibiotics. The pathogenic bacteria have then become resistant to the drug that is intended to kill them. A human cannot be antibiotic-resistant but a human can carry antibiotic-resistant bacteria. Resistant bacteria can be spread between humans, animals and in the environment.
Common causes of antibiotic resistance
- Overuse of antibiotics
- Failure by patients to complete a course of antibiotics
- Overuse of antibiotics in animal agriculture
- Poor infection control in hospitals and clinics
- Inadequate sanitary conditions
Subscribe to the newsletter
Resist the Resistance is an initiative to address the global challenge of #AntibioticResistance. Initiated by BioGaia. Subscribe to the newsletter Resist the resistance to learn more about antibiotic resistance. Subscribe here
In our bodies there is a constant battle going on between good and bad bacteria. Common disorders, like colic, constipation and diarrhea, are often a sign that the bad bacteria has the upper hand.
To date, 184 clinical studies using BioGaia’s human strains of Lactobacillus reuteri have been performed on 15,500 individuals of all ages (February 2018).
BioGaia's probiotic strains
BioGaia’s probiotic products with L. reuteri are among the most scientifically well-documented probiotics in the world with regard to both efficacy and safety, tested in 15,500 infants, children and adults.